Clinical trial
A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the…
NCT00001839 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00001839 |
|---|---|
| Title | A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome |
| Official title | A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hematologic Diseases, Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | Antithymocyte globulin, Cyclosporine |
| Enrollment | 182 |
| Start date | Dec 1, 1998 |
| Completion | May 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: